Tovorafenib Impurity 29 | CAS 1097250-86-6 - Request Quote
Tovorafenib Impurity 29
| SZ CAT No: | SZ-T202037 |
| CAS No | 1097250-86-6 |
| Mol.F. | C7H8ClN3O2 |
| Mol.Wt. | 201.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tovorafenib Impurity 29 is chemically Ethyl 6-amino-5-chloropyrimidine-4-carboxylate. Tovorafenib Impurity 29 is supplied with detailed characterization data compliant with regulatory guideline. Tovorafenib Impurity 29 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tovorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1097250-86-6
Purchase 1097250-86-6
Order 1097250-86-6
Enquire 1097250-86-6
price of 1097250-86-6
1097250-86-6 Supplier
1097250-86-6 Manufacturer
1097250-86-6 Exporter
buy high quality Tovorafenib Impurity 29
Purchase Tovorafenib Impurity 29
Tovorafenib Impurity 29 suppliers
Tovorafenib Impurity 29 manufacturers
Tovorafenib Impurity 29 price
Order Tovorafenib Impurity 29
Enquire Tovorafenib Impurity 29
Tovorafenib Impurity 29 cost
Tovorafenib Impurity 29 Supplier
Tovorafenib Impurity 29 Distributor
Tovorafenib Impurity 29 for Method Validation
Tovorafenib Reference Standard
Tovorafenib Impurity 29 for ANDA Filing
Tovorafenib Impurity 29 for Forced Degradation Studies
Tovorafenib Impurity 29 Identification Standards
Tovorafenib Impurity 29 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


